Hypomyelinating leukodystrophies: Translational research progress and prospects

Petra J. W. Pouwels, Adeline Vanderver, Genevieve Bernard, Nicole I. Wolf, Steffi F. Dreha-Kulczewksi, Sean C. L. Deoni, Enrico Bertini, Alfried Kohlschütter, William Richardson, Charles ffrench-Constant, Wolfgang Köhler, David Rowitch, A. James Barkovich

Research output: Contribution to journalReview articlepeer-review

118 Citations (Scopus)


Hypomyelinating leukodystrophies represent a genetically heterogeneous but clinically overlapping group of heritable disorders. Current management approaches in the care of the patient with a hypomyelinating leukodystrophy include use of serial magnetic resonance imaging (MRI) to establish and monitor hypomyelination, molecular diagnostics to determine a specific etiology, and equally importantly, careful attention to neurologic complications over time. Emerging research in oligodendrocyte biology and neuroradiology with bedside applications may result in the possibility of clinical trials in the near term, yet there are significant gaps in knowledge in disease classification, characterization, and outcome measures in this group of disorders. Here we review the biological background of myelination, the clinical and genetic variability in hypomyelinating leukodystrophies, and the insights that can be obtained from current MRI techniques. In addition, we discuss ongoing research approaches to define potential outcome markers for future clinical trials.

Original languageEnglish
Pages (from-to)5-19
Number of pages15
JournalAnnals of Neurology
Issue number1
Early online date11 Jun 2014
Publication statusPublished - Jul 2014

Cite this